{"created":"2023-06-23T12:18:38.152559+00:00","id":9332,"links":{},"metadata":{"_buckets":{"deposit":"c78e8a8c-d37e-4eed-a2a6-c8b8f6104cb7"},"_deposit":{"created_by":19,"id":"9332","owners":[19],"pid":{"revision_id":0,"type":"depid","value":"9332"},"status":"published"},"_oai":{"id":"oai:asahi-u.repo.nii.ac.jp:00009332","sets":["64:79"]},"author_link":["12816"],"item_10_creator_30":{"attribute_name":"教員氏名","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"堀部, めぐみ"}],"nameIdentifiers":[{"nameIdentifier":"12816","nameIdentifierScheme":"WEKO"}]}]},"item_10_date_36":{"attribute_name":"発行又は発表の年月","attribute_value_mlt":[{"subitem_date_issued_datetime":"2018-01"}]},"item_10_textarea_29":{"attribute_name":"業績分類","attribute_value_mlt":[{"subitem_textarea_value":"　学術雑誌論文"}]},"item_10_textarea_31":{"attribute_name":"発行、発表雑誌等、又は発表学会等の名称","attribute_value_mlt":[{"subitem_textarea_value":"Nursing Open. "}]},"item_10_textarea_33":{"attribute_name":"号","attribute_value_mlt":[{"subitem_textarea_value":"5"}]},"item_10_textarea_34":{"attribute_name":"掲載ページ","attribute_value_mlt":[{"subitem_textarea_value":"131-138"}]},"item_10_textarea_35":{"attribute_name":"単著、共著の別","attribute_value_mlt":[{"subitem_textarea_value":"共著"}]},"item_10_textarea_42":{"attribute_name":"概要","attribute_value_mlt":[{"subitem_textarea_value":"FDAに有害事象として報告された薬剤と、産後うつ病の関連性を分析した。2004-2015年の報告では、レボノルゲストレル、エトノゲストレル、セルトラリンおよびドロスピレノンのオッズ比（95％信頼区間、CI）は、12.5 （8.5-22.8）、12.2（6.5-23.1）、5.4（2.7-10.9）であった。避妊薬またはプロゲストゲンを伴う子宮内装置の使用は、産後うつ病のリスクの可能性が示唆された。JSPS KAKENHI Grant Number, 24390126"}]},"item_access_right":{"attribute_name":"アクセス権","attribute_value_mlt":[{"subitem_access_right":"metadata only access","subitem_access_right_uri":"http://purl.org/coar/access_right/c_14cb"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"eng"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"other","resourceuri":"http://purl.org/coar/resource_type/c_1843"}]},"item_title":"Contraceptives as possible risk factors for postpartum depression: A retrospective study of the food and drug administration adverse event reporting system, 2004–2015","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"Contraceptives as possible risk factors for postpartum depression: A retrospective study of the food and drug administration adverse event reporting system, 2004–2015"}]},"item_type_id":"10","owner":"19","path":["79"],"pubdate":{"attribute_name":"公開日","attribute_value":"2018-10-19"},"publish_date":"2018-10-19","publish_status":"0","recid":"9332","relation_version_is_last":true,"title":["Contraceptives as possible risk factors for postpartum depression: A retrospective study of the food and drug administration adverse event reporting system, 2004–2015"],"weko_creator_id":"19","weko_shared_id":-1},"updated":"2023-06-23T13:44:45.894873+00:00"}